149 related articles for article (PubMed ID: 14594503)
1. Immunostimulatory oligonucleotides: ready for immunotherapy prime time!
Tam YK
J Hematother Stem Cell Res; 2003 Oct; 12(5):467-71. PubMed ID: 14594503
[No Abstract] [Full Text] [Related]
2. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.
Jahrsdörfer B; Weiner GJ
Curr Opin Investig Drugs; 2003 Jun; 4(6):686-90. PubMed ID: 12901226
[TBL] [Abstract][Full Text] [Related]
4. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections.
Harandi AM; Holmgren J
Curr Opin Investig Drugs; 2004 Feb; 5(2):141-5. PubMed ID: 15043387
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides.
Ishii KJ; Gursel I; Gursel M; Klinman DM
Curr Opin Mol Ther; 2004 Apr; 6(2):166-74. PubMed ID: 15195929
[TBL] [Abstract][Full Text] [Related]
6. CpG oligonucleotides as immune adjuvants.
Krieg AM
Ernst Schering Res Found Workshop; 2000; (30):105-18. PubMed ID: 10943319
[No Abstract] [Full Text] [Related]
7. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
Chaung HC
Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in immunostimulatory CpG oligonucleotides.
Rothenfusser S; Tuma E; Wagner M; Endres S; Hartmann G
Curr Opin Mol Ther; 2003 Apr; 5(2):98-106. PubMed ID: 12772497
[TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvants as potential cancer immunotherapeutics.
Temizoz B; Kuroda E; Ishii KJ
Int Immunol; 2016 Jul; 28(7):329-38. PubMed ID: 27006304
[TBL] [Abstract][Full Text] [Related]
10. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
Krieg AM
Curr Oncol Rep; 2004 Mar; 6(2):88-95. PubMed ID: 14751085
[TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory DNA-based therapeutics for experimental and clinical allergy.
Horner AA; Takabaysahi K; Zubeldia JM; Raz E
Allergy; 2002; 57 Suppl 72():24-9. PubMed ID: 12144550
[TBL] [Abstract][Full Text] [Related]
12. Complex roles of CpG in liposomal delivery of DNA and oligonucleotides.
Wilson A; Pitt B; Li S
Biosci Rep; 2002 Apr; 22(2):309-22. PubMed ID: 12428907
[TBL] [Abstract][Full Text] [Related]
13. CpG DNA in cancer immunotherapy.
Weiner GJ
Curr Top Microbiol Immunol; 2000; 247():157-70. PubMed ID: 10689786
[No Abstract] [Full Text] [Related]
14. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
Davila E; Kennedy R; Celis E
Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory CpG oligodeoxynucleotides increase resistance against amoebic gill disease in Atlantic salmon, Salmo salar L.
Bridle AR; Butler R; Nowak BF
J Fish Dis; 2003 Jun; 26(6):367-71. PubMed ID: 12899412
[No Abstract] [Full Text] [Related]
16. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
17. Antisense and/or immunostimulatory oligonucleotide therapeutics.
Agrawal S; Kandimalla ER
Curr Cancer Drug Targets; 2001 Nov; 1(3):197-209. PubMed ID: 12188879
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory oligonucleotides in therapy of allergic diseases.
Lazarczyk M; Grzela K; Grzela T
Expert Opin Biol Ther; 2005 Apr; 5(4):525-36. PubMed ID: 15934830
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory DNA for asthma: better than eating dirt.
Silverman ES; Drazen JM
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):645-7. PubMed ID: 12760961
[No Abstract] [Full Text] [Related]
20. Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.
Yu D; Kandimalla ER; Zhao Q; Bhagat L; Cong Y; Agrawal S
Bioorg Med Chem; 2003 Feb; 11(3):459-64. PubMed ID: 12517441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
